Researcher
Min Thura is a Senior Scientist II at the PRL3 phosphatase and cancer therapy lab in A*STAR Institute of Molecular and Cell Biology (A*STAR IMCB). He has been actively working on the pre-clinical and clinical development of PRL3 biology and therapeutics since 2012. He obtained his MBBS and Master of Medical Sciences from the University of Medicine (1), Yangon, Myanmar in 1993 and 2003 respectively. He also obtained his PhD from the Hamamatsu University School of Medicine, Japan in 2009. Thura is a biomedical scientist with a unique foundation as a clinician and comprehensive exposure across research and development, clinical practice, healthcare management and regulatory affairs.
Related Articles
Broad new hope for late-stage IV cancer
30 Oct 2025Clinical trial results show a new antibody drug with an unconventional approach improves survival for



